UK Medical Cannabis Alliance

Our new webinar series will confront the hard truths facing the UK #medicalcannabis sector. Our first session will ask what we can learn from Australia's experience. Submit questions to our expert panel now by replying to this tweet

Got it

The CRDG will focus relentlessly on creating an environment for vital advanced clinical trials and scientific research into cannabinoids to take place here in the UK /ENDS

This new task force is initially supported by seven industry partners and will be consulting on its plans in the coming months with a view to producing its first strategy paper to the new government in July. The group will be formally constituted this summer.

So today our parent company has launched a new group - @crdguk - to propel scientific research and development of pharmaceutical cannabinoid-related products in the UK - more here crdg.uk 1/

. @crdguk aims to build a robust ecosystem by integrating universities, research institutions, investors, businesses, and the NHS – driving innovation and development, nurturing top talent and fostering advances in healthcare.

Our ambition is to develop and implement a comprehensive strategy to transform the UK into the global leader in cannabinoid research and medicine development 2/

Our first articles garnered a strong response, and we're looking to build on that. So if you're working in this space and have something to say, get in touch with jimmy@medicalcannabisalliance.org and let us know

That's why we created the Medical Cannabis Journal – to educate, provide a rallying point, and seed the debates the sector must have to support sustainable growth medicalcannabisjournal.substack.com

As an industry in its infancy, the UK's #medicalcannabis sector needs a voice

Find out more by following us on @LinkedIn through this link: linkedin.com/feed/update/ur…

And finally, is there anything we are not doing, that Australia is, that would help improve the UK situation within current UK regulations?

MCAired is a webinar series for growing the #medicalcannabis sector in the UK. The first episode will focus on Australia, asking what lessons the UK medical cannabis industry can learn from the country's successes and mistakes. So what exactly will we be looking at?

The best estimates put UK #medicalcannabis patient numbers at 32,000. Australia, with half the population, has 320,000. The question is, why? Join our upcoming webinar series to find out why